0820 GMT - The medical technology sector is set for another volatile year in 2025, with investors looking for "safe havens" with less exposure to tariff risks and resilience to macro uncertainty, Berenberg analysts say. Swiss-American Alcon and the U.K's Hikma, who manufacture a large proportion of their products where they are sold, have some degree of pricing power to offset cost inflation as a result of tariffs, the analysts write in a note. Investors' worries center on the risk of a potential U.S. recession due to tariffs that would lead to falling demand for med-techs with significant consumer exposure in the U.S., such as Switzerland's Straumann and Germany's Carl Zeiss Meditec, they say. Despite the market turmoil, investor interest in the sector remains high, the analysts add.(helena.smolak@wsj.com)
(END) Dow Jones Newswires
April 08, 2025 04:20 ET (08:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。